Navigation Links
CEL-SCI Corporation Releases Letter to Shareholders
Date:7/7/2009

Factors that could cause or contribute to such differences include, an inability to duplicate the clinical results demonstrated in clinical studies, timely development of any potential products that can be shown to be safe and effective, receiving necessary regulatory approvals, difficulties in manufacturing any of the Company's potential products, inability to raise the necessary capital and the risk factors set forth from time to time in CEL-SCI Corporation's SEC filings, including but not limited to its report on Form 10- K/A for the year ended September 30, 2008. The Company undertakes no obligation to publicly release the result of any revision to these forward-looking statements which may be made to reflect the events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

For more information, please visit www.cel-sci.com.


'/>"/>
SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. CEL-SCI to Present at the Noble Financial Conference
2. CEL-SCI CORPORATION Manufacturing Facility for Pivotal Phase III Cancer Trial Scheduled to Be Completed During 2008 Third Quarter
3. CEL-SCI Announces Exclusive Licensing Agreement with Teva for Cancer Drug Multikine
4. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
5. CEL-SCI Takes Delivery of New Manufacturing Facility
6. Updated Pictures of CEL-SCI Manufacturing Facility Available Online
7. CEL-SCI Corporation Releases Letter to Shareholders
8. CEL-SCI Corporation Announces 2008 Financial Results
9. CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products
10. CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease
11. CEL-SCIs L.E.A.P.S. Technology Shows Potential to Treat Swine Influenza in Preclinical Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... EvoDerma ’s NOOME Anti-Aging Motion has been ... comes with a second treatment cup to help prevent and ... cup is thinner on the edges for a softer contact ... and uneven surfaces on the face, neck and décolleté. Choose ... on areas such as the cheeks and neck, or opt ...
(Date:7/10/2014)... Ind. , July 10, 2014 /PRNewswire/ ... its use of capnography for respiratory monitoring ... group of healthcare leaders in embracing state-of-the-art ... how effectively patients are breathing and can ... occurs. By measuring the amount of carbon ...
(Date:7/10/2014)... DALLAS , July 10, 2014  Kainos Capital, ... consumer brands, today announced that it has acquired the ... stake in the business. Terms of the transaction were ... loss and meal replacement business that markets ready-to-drink shakes, ... North America and in the ...
(Date:7/10/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/s3bqj2/photonic ... "International Photonic Integrated Circuit (Monolithic Integration, Hybrid Integration, ... report to their offering. ... photonic integration traces its roots in the latter ... photonic integration went unexplored and unfulfilled for several ...
Breaking Biology Technology:Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2Kainos Capital Acquires Slim-Fast From Unilever 2International Photonic Integrated Circuit (Monolithic Integration, Hybrid Integration, Module Integration) Market - Forecasts to 2019 2
... SAN DIEGO, March 3, 2011 Anadys Pharmaceuticals, Inc. (Nasdaq: ... patient care by developing novel medicines for the treatment of ... for the fourth quarter and year ended December 31, 2010. ... well-positioned to create value in the evolving HCV landscape," said ...
... 2011 Novavax, Inc. (Nasdaq: NVAX ) ... visit the company,s headquarters in Rockville, Maryland, on Monday, ... at up to $179 million. The Office of Biomedical ... of the Assistant Secretary for Preparedness and Response at ...
... Executive search firm Sanford Rose Associates® - Minneapolis ... engagement for Nordson Corporation: Lise W. Duran as General ... of biomaterial applicators used in a wide variety of ... years of experience in the medical device industry, having ...
Cached Biology Technology:Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2010 Financial Results and Highlights 2Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2010 Financial Results and Highlights 3Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2010 Financial Results and Highlights 4Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2010 Financial Results and Highlights 5Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2010 Financial Results and Highlights 6Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2010 Financial Results and Highlights 7Maryland Governor Martin O'Malley to Visit Novavax in Celebration of HHS-BARDA Contract Award 2Maryland Governor Martin O'Malley to Visit Novavax in Celebration of HHS-BARDA Contract Award 3Maryland Governor Martin O'Malley to Visit Novavax in Celebration of HHS-BARDA Contract Award 4Sanford Rose Associates® - Minneapolis Fills Key Management Position for the Micromedics Operation of Nordson Corporation 2
(Date:7/10/2014)... , July 7, 2014 Fingerprint Cards, ... major design win (DW). A Chinese Top 5 smartphone OEM ... start of mass production in October 2014.   ... Top 5 smartphone OEM, which has a planned date for ... target sales volume for this phone of 3 million units. ...
(Date:7/10/2014)... GOTHENBURG, Sweden , July 8, 2014 ... FPC1021 has won a new design win (DW). An Asian ... targeted date for mass production start in August 2014.   ... an Asian smartphone OEM, which has a planned date for ... received an initial ramp order of SEK 5M, for delivery ...
(Date:7/10/2014)... Ill. , July 9, 2014 ... (EHR), spurred in large part by meaningful use ... health care providers interact with laboratory information. Now, ... in the field of clinical informatics in order ... To address the educational needs of ...
Breaking Biology News(10 mins):FPC Wins DW for 1021 Touch Sensor for Flagship Smartphone from Chinese Top 5 Smartphone OEM 2FPC Wins DW and Initial Ramp Order for FPC1021 Touch Sensor for Flagship Smartphone from Asian OEM 2New Clinical Informatics Curriculum Prepares Future Pathologists 2New Clinical Informatics Curriculum Prepares Future Pathologists 3New Clinical Informatics Curriculum Prepares Future Pathologists 4
... Marta Barrachina, Institute of Neuropathology of the Bellvitge Biomedical ... patients suffering from schizophrenia characterized by motor disorders. ... collaboration with the research team Mairena Martin at the ... clinical researchers of the Health Park Sant Joan de ...
... The Clinical Nutrition Research Centre (CNRC) -- a ... and Research (A*STAR) and National University Health Systems (NUHS) ... that will conduct nutritional studies to understand the causes ... develop products and formulate diets that can reduce the ...
... LAKE CITY, Utah, Jan. 29, 2014 Myriad Genetics, ... a clinical utility study with its Prolaris test, at ... Calif. The study demonstrated the significant clinical value ... prostate cancer. Prolaris is a prognostic test that ...
Cached Biology News:Identified a subgroup of schizophrenia patients with motor disorders 2Asia's first under-1-roof Nutritional Research Centre set up in Singapore 2Asia's first under-1-roof Nutritional Research Centre set up in Singapore 3Asia's first under-1-roof Nutritional Research Centre set up in Singapore 4Myriad's Prolaris significantly modifies treatment decisions for prostate cancer patients 2